News & Analysis on Clinical Trial Services & Contract Research And Development
Dutch group DSM, one of Europe's top three ingredient suppliers to drug makers, increased sales of pharma products during the second quarter but continued losses from the antibiotics market halved the Life Sciences operating profit.
Bayer Biological Products has unveiled a number of new product developments as part of its major campaign to combat product tampering and counterfeiting.
Switzerland's Lonza Group said yesterday that it will use a novel process developed by US-based biocatalysis company Codexis for the synthesis of a key chiral pharmaceutical compound used in one of the world's major human therapeutics products.